Healthcare Triangle, Inc. HCTI
EDP Services · IPO 2021 · data as of November 13, 2026
Healthcare Triangle, Inc. (HCTI) is a technology company listed in the US with a market value of about $3M. In the twelve months to September 30, 2026 it had revenue of $31M and net income of -$18M, a net margin of -56.4%.
Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is future growth (1/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of -15% a year, a 5-year average ROIC of -84%.
About Healthcare Triangle
Healthcare Triangle is listed in the US and classified in edp services, IPO year 2021. Revenue went from $31M in 2020 to $14M in 2025, a decline of about 15.0% a year. It was profitable in 1 of the last 6 years in our data. Its share count rose by 24914% over three years (dilution for shareholders). It spends 4% of revenue on research and development.
Score: 0.6 / 5
Checks passed
- Revenue growth above 10% last year
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $31M | $14M | $12M | $33M | $46M | $35M | $31M |
| Net income | -$18M | -$9M | -$6M | -$9M | -$14M | -$6M | $2M |
| Free cash flow | — | -$17M | — | -$2M | -$5M | -$7M | — |
| EPS (diluted) | $-19.02 | $-10.15 | $-1127.29 | $-2073.44 | $-3867.76 | $-201.36 | $83.73 |
| Net margin | -56.4% | -68.2% | -51.0% | -26.2% | -31.3% | -16.9% | 7.5% |
| ROIC | — | -24.8% | -0.4% | -243.8% | -125.4% | -25.5% | 20.9% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 1 analysts is $63.00, 1621% above the current price; targets range from $63.00 to $63.00; the consensus rating is “none”; expected EPS is $-204.60 for the fiscal year ending December 31, 2026.
Frequently asked questions
Does Healthcare Triangle pay a dividend?
Not currently.
Is Healthcare Triangle a good stock to buy?
We do not give buy or sell advice. Healthcare Triangle scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.